| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/29/2004 | US20040018534 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein |
| 01/29/2004 | US20040018521 Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease |
| 01/29/2004 | US20040018516 Ixodes scapularis tissue factor pathway inhibitor |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | US20040018511 Genetic markers and polymorphisms in the bovine somatostatin (SST) locus, as well as haplotypes that are associated with certain desirable traits such as marbling |
| 01/29/2004 | US20040018510 Human calcium channel compositions and methods |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018503 Nucleotide sequence of the haemophilus influenza Rd genome, fragments thereof, and uses thereof |
| 01/29/2004 | US20040018499 Human extracellular messengers (XMES) and polynucleotides which identify and encode XMES; methods for diagnosing, treating or preventing disorders associated with aberrant expression of XMES |
| 01/29/2004 | US20040018497 Human obesity LIPIN3 polynucleotide and polypeptide sequences and methods of use thereof |
| 01/29/2004 | US20040018487 Methods of diagnosing cervical cancer |
| 01/29/2004 | US20040018226 Electroprocessing of materials useful in drug delivery and cell encapsulation |
| 01/29/2004 | US20040018211 EIA vaccine and diagnostic |
| 01/29/2004 | US20040018209 Abundant extracellular products and methods for their production and use |
| 01/29/2004 | US20040018208 A part of the coding sequence of the middle glycoprotein of the hepatitis B virus, which has a dna sequence coding for at least one tumor epitope of a tumor antigen inserted |
| 01/29/2004 | US20040018207 Preventive and therapeutic AIDS vaccines |
| 01/29/2004 | US20040018205 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 01/29/2004 | US20040018204 Compositions and methods for WT1 specific immunotherapy |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018189 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 01/29/2004 | US20040018188 Sparc-related proteins |
| 01/29/2004 | US20040018183 Modified natural killer cell lines and methods of use |
| 01/29/2004 | US20040018182 Thymidine kinase expressing natural killer cell lines and methods of use |
| 01/29/2004 | US20040018181 MUC1 interference RNA compositions and methods derived therefrom |
| 01/29/2004 | US20040018173 Composition and method for the treatment and prevention of metastatic disorders |
| 01/29/2004 | US20040018172 Interferon alpha hybrids |
| 01/29/2004 | US20040018171 Biochemical conjugates comprising tumor necrosis factor or interferons and ligands of CD antigen receptors, used as anticarcinogenic agents |
| 01/29/2004 | US20040018170 Chimeric proteins comprising death domains fused to biotin-streptavidin binding pairs, administered for prophylaxis of asthma, allergies, poisoning, autoimmune or graft versus host disease |
| 01/29/2004 | DE19964268B4 Verfahren zum Screenen einer Verbindung, welche die Wechselwirkung zwischen IGF-1R und einem der Polypeptide IIP-1 bis IIP-10 hemmt A method for screening a compound which inhibits the interaction between IGF-1R and IIP-one of the polypeptides 1 to IIP-10 |
| 01/29/2004 | DE19952982B4 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 01/29/2004 | DE10231588A1 Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen The transgenic expression constructs and methods for increasing the vitamin E content in plant organisms |
| 01/29/2004 | DE10231587A1 Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen The transgenic expression constructs and methods for increasing the vitamin E content in plant organisms |
| 01/29/2004 | DE10231574A1 Membran, Vorrichtung und Verfahren zum Entfernen von Proteasen aus Flüssigkeiten Membrane, apparatus and methods for removing fluids from proteases from |
| 01/29/2004 | CA2493706A1 Igg fc/hiv-gp120/c3d fusion protein |
| 01/29/2004 | CA2493432A1 Fusion proteins comprising a modified albumin signal sequence |
| 01/29/2004 | CA2493406A1 Gm-negative ehv-mutants without heterologous elements |
| 01/29/2004 | CA2493263A1 Novel gene associated with rheumatoid arthritis |
| 01/29/2004 | CA2493064A1 Tumor treating combinations, compositions and methods |
| 01/29/2004 | CA2493062A1 Tumor treating composition and methods |
| 01/29/2004 | CA2493007A1 Protein complexes of the tip60 transcriptional activator protein |
| 01/29/2004 | CA2492919A1 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 01/29/2004 | CA2492806A1 Targeted agents for nerve regeneration |
| 01/29/2004 | CA2492728A1 Monomeric insulin |
| 01/29/2004 | CA2492598A1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2492377A1 Recombinant production of mixtures of antibodies |
| 01/29/2004 | CA2492048A1 Detection of chemical ligation using fluorescence quenching leaving groups |
| 01/29/2004 | CA2492017A1 Npc1l1 (npc3) and methods of use thereof |
| 01/29/2004 | CA2491946A1 Ghrelin analogs |
| 01/29/2004 | CA2489008A1 Ghrelin-carrier conjugates |
| 01/29/2004 | CA2487849A1 Hapten-carrier conjugates comprising virus like particles and uses thereof |
| 01/29/2004 | CA2467691A1 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/28/2004 | EP1384784A1 Method for reversible inhibition of gene expression by modified ribonucleoproteins |
| 01/28/2004 | EP1384782A1 Method of detecting the expression of aspergillus gene |
| 01/28/2004 | EP1384781A1 Methods for Modulating T-Cell Survival by Modulating BCL-XL Protein Level |
| 01/28/2004 | EP1384778A1 Process for synthesizing protein using cell-free protein synthesis system |
| 01/28/2004 | EP1384725A2 Factor Xa inhibitors |
| 01/28/2004 | EP1384485A1 Bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
| 01/28/2004 | EP1384077A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/28/2004 | EP1383931A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/28/2004 | EP1383930A1 Method and kit for diagnosing gh deficiency |
| 01/28/2004 | EP1383929A2 Genes expressed in intestinal epithelium and peyer's patch m cells |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383924A2 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383919A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/28/2004 | EP1383916A2 Trac1: modulators of lymphocyte activation |
| 01/28/2004 | EP1383906A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated dgsa gene |
| 01/28/2004 | EP1383905A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated acea gene |
| 01/28/2004 | EP1383900A2 Freeze-tolerant eukaryotic cells |
| 01/28/2004 | EP1383896A2 Haemophilus influenzae antigens |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383894A2 Molecules for disease detection and treatment |
| 01/28/2004 | EP1383893A2 Proteins and nucleic acids encoding same |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383889A1 Modified organs and cells for xenotransplantation |
| 01/28/2004 | EP1383888A2 Human secreted proteins |
| 01/28/2004 | EP1383883A2 Asthma-associated snps around microsatellite marker d2s308 and identification of human prolyl-oligopeptidase-dpp10 |
| 01/28/2004 | EP1383878A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 01/28/2004 | EP1383870A2 A 150 kda tgf-beta 1 accessory receptor acting as a negative modulator of tgf-beta signaling |
| 01/28/2004 | EP1383803A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/28/2004 | EP1383802A2 Anti-muc-1 single chain antibodies for tumor targeting |
| 01/28/2004 | EP1383801A1 Antibodies against cancer |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383797A2 Markers of unstable atherosclerotic plaques |
| 01/28/2004 | EP1383796A1 Neurovirulent strain of the west nile virus and applications thereof |
| 01/28/2004 | EP1383795A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/28/2004 | EP1383793A2 Insulin and igf-1 receptor agonists and antagonists |
| 01/28/2004 | EP1383791A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/28/2004 | EP1383790A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383784A1 A hepatitis b virus surface antigen mutant and methods of detection thereof |
| 01/28/2004 | EP1383783A2 Leinamycin biosynthesis gene cluster and its components and their uses |
| 01/28/2004 | EP1383781A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/28/2004 | EP1383543A1 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/28/2004 | EP1383538A2 Oral absorbed drugs |
| 01/28/2004 | EP1383535A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof |
| 01/28/2004 | EP1383534A2 Chlamydia vaccine composition |
| 01/28/2004 | EP1383533A2 Proteins and nucleic acids encoding same |
| 01/28/2004 | EP1383530A2 Laminin 5, 13 and 14 and uses thereof |